Immuno-oncology is the study and development of treatments that leverages the immune system of the body for fighting against cancer. The immune system of a body is a complex network of organs, cells, and molecules that protects the human body from a foreign substance including bacteria and viruses that may lead to the occurring of an infection. Apart from finding and destroying foreign substances, the immune system of the body is capable of locating and attacking abnormal cells. For precision cancer treatments, researchers and scientists are working on the development of new techniques and technologies that can harness the natural defense system of the body for targeting and eradicating cancer cells. The global immuno-oncology assay market size is expected to expand at a significant rate owing to various factors such as increasing adoption of targeted therapy coupled with the rising incidence of cancer. Further, the advancement in technology in molecular diagnostics, extensive R&D in cancer diagnostics, and increasing ongoing clinical trials in immunotherapy further contribute to the growth of the market.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/immuno-oncology-assay-market
Increasing prevalence of cancer is primarily expected to drive the global immuno-oncology assay market over the forecast period. According to the World Health Organization (WHO), the global cancer burden has risen to 18.1 million new cases and 9.6 million mortalities in 2018. Further, the aforementioned organization estimates that 1 in 5 men and 1 in 6 women, across the globe, develop cancer during their lifetime. Moreover, the disease has a mortality rate of nearly 1 in 8 men and 1 in 11 women. Globally, 43.8 million people are alive within 5 years of a cancer diagnosis. The increasing burden of cancer is attributed to various factors such as surging aging population, change in lifestyle, growing incidence and prevalence rate of certain cancer diseases.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/immuno-oncology-assay-market
Market Segmentation
Global Immuno-Oncology Assay Market by Technology
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Immunoassays
- Other Technologies (Flow Cytometry)
Global Immuno-Oncology Assay Market by Cancer Type
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Bladder Cancer
- Others
Global Immuno-Oncology Assay Market by Application
- Clinical Diagnostic
- Research
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- Agilent Technologies, Inc.
- Almac Group Ltd.
- AstraZeneca PLC
- Biodesix, Inc.
- Bio-Rad Laboratories, Inc.
- Charles River Laboratories International, Inc.
- Crown Bioscience Inc.
- Hoffmann-La Roche Ltd
- Foundation Medicine, Inc.
- Horizon Discovery Group PLC
- HTG Molecular Diagnostics, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
